Innovate UK

The test is a 15-biomarker quantitative PCR panel used to stratify patients with Crohn's disease and ulcerative colitis based on the severity of their illness.

The synthesis method will be incorporated into the silicon array the company developed to produce DNA at scale.

Businesses can now apply for a share of the funds to develop new technologies that increase the UK's capacity to carry out genomic analysis.

The collaborators aim to show that Cytox' VariaTect SNP profiling array and an associated algorithm can effectively predict the presence of Alzheimer's pathology.

The British company has announced the results of two studies showcasing the ability of its EpiSwitch platform to diagnose and stage breast cancer and ALS patients.

The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.

The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.

The national program to set up local innovation hubs will collaborate with regional experts in government, academia, and the healthcare industry.

The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.

The consortium comprises Oxford BioDynamics,OxfordUniversityresearchers, and Chronos Therapeutics.

Pages

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.